Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02396615
Other study ID # B318
Secondary ID
Status Completed
Phase N/A
First received February 19, 2015
Last updated April 21, 2015
Start date February 2015
Est. completion date April 2015

Study information

Verified date April 2015
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority Denmark: The National Committee on Health Research Ethics
Study type Interventional

Clinical Trial Summary

The objective of the study is to establish whether a Pineapple juice with Viscofiber and Red ginseng can enhance satiety and reduce appetite and/or accelerate satiation in the short-term.


Description:

A double-blind, randomised crossover design will be employed with an experimental (active) condition and a control condition at least one week apart. After having successfully completed screening procedures eligible participants will be invited for two separate test days, at least 7 days apart. On the two test days, the products will be provided in a randomized order as part of a fixed breakfast meal, and subjective appetite ratings will be measured every 30 min for the following 8 hours. Satiety and satiation will be measured through administration of test meals in the laboratory supplied with controlled food intake under free-living conditions


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date April 2015
Est. primary completion date April 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Participants who have provided written informed consent

- Healthy men and women

- Ages between 18 and 55 years

- BMI between 25.0-31.9 kg/m2

- Regular breakfast eaters (eating breakfast = 4 times a week)

- Regular menstrual periods (women only)

Exclusion Criteria:

- Significant health problems as judged by the investigator

- Taking any medication or supplements known to affect appetite or body weight within the past month and/or during the study as judged by the investigator

- Pregnant, planning to become pregnant within the next 4 weeks or breastfeeding (women only)

- History of anaphylaxis to food

- Any known food allergies or food intolerance

- Smoking, smoking cessation within the past 3 months or nicotine use (electronic cigarettes)

- Self-reporting currently dieting or having lost/gained significant amount of weight (±3 kg) in the previous 3 months

- Significant changes in physical activity patterns in the past 4 weeks or intention to change during the study as judged by the investigator

- Significant change in diet in the past 4 weeks or intention to change the diet during the study as judged by the investigator

- Use of systemic or local treatment likely to interfere with evaluation of the study parameters as judged by the investigator

- Participants who work in appetite or feeding related areas

- Participants not able to comply with the study protocol

- Post-menopausal (women only)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
SATIN pineapple
Active juice with added fibre and ginseng
SATIN pineapple control
Control products without active ingredients

Locations

Country Name City State
Denmark University of Copenhagen Copenhagen Frederiksberg

Sponsors (3)

Lead Sponsor Collaborator
University of Copenhagen University of Leeds, University of Liverpool

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ad libitum energy intake Total ad libitum energy intake during test day 1 Baseline (week 0) No
Primary Ad libitum energy intake Total ad libitum energy intake during test day 2 Test day 2 (week 1) No
Secondary VAS score for appetite sensation - hunger Perceptions of hunger, assessed using 100 mm VAS scales Every 30 min during test day 1 and test day 2 No
Secondary Eating behaviour questionnaire - binge eating scale Questionnaire by Gormally et al. 1982 Screening No
Secondary Eating behaviour questionnaire - Control of Eating Questionnaire by Hill et al. 1991 screening No
Secondary Eating behaviour questionnaire - three factor eating questionnaire Three Factor Eating Questionnaire by Stunkard and Messick, 1985 screening No
Secondary Eating behaviour questionnaire- power of food Power of food scale by Lowe et al 2009 screening No
Secondary VAS score for appetite sensation - fullness Perceptions of fullness, assessed using 100 mm VAS scales every 30 min during test day 1 and test day 2 No
Secondary VAS score for appetite sensation - Desire to eat Perceptions of Desire to eat, assessed using 100 mm VAS scales every 30 min during test day 1 and test day 2 No
Secondary VAS score for appetite sensation - prospective consumption Perceptions of prospective suncumption, assessed using 100 mm VAS scales every 30 min during test day 1 and test day 2 No
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1